resi conference series - next phase newsletter · • there are 2,500 active global investors in...

15
© LSN Holdings Global Life Science Partnering Platform RESI CONFERENCE SERIES Life Science Nation, LLC 9 Hamilton Place, Suite 2B, Boston, MA 02108 Cell: (617) 930 4299 Email: [email protected] www.resiconference.com Dennis Ford, Founder & CEO, Life Science Nation

Upload: others

Post on 22-Jun-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

RESI CONFERENCE SERIES

Life Science Nation, LLC9 Hamilton Place, Suite 2B, Boston, MA 02108

Cell: (617) 930 4299Email: [email protected]

www.resiconference.com

Dennis Ford, Founder & CEO, Life Science Nation

Page 2: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

LSN’s Global Life Science Partnering Platform

$130k

$483k

$901k

$1.4M

$1.94M

1

Page 3: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

RESI Has 3 Compelling Game Changing Attributes

2

1. RESI is actually a real investor conference. By leveragingthe LSN’s Investor Database, RESI regularly delivers highly qualified global early stage life science investors with vetted investment mandates to a bevy of early stage CEO’s seeking capital for the latest drugs, devices, diagnostics and health IT (RESI is cross domain) products that they are inventing.

2. RESI conference series has created a unique format that runs every few months and facilitates both the Fundraising CEOs and the Investors to incorporate the RESI meeting into their month to month business schedules making RESI very sticky and a vehicle to come from dialogue to relationship.

3. LSN has developed an expert system that not only ranks technology assets but also matches the right technology asset to the right investor making RESI partnering meetings extremely compelling and efficient for both the buyside and sellside.

RESI(JPM)

RESI(MaRS)

RESI(BIO)

RESIBOS

RESINYC

Technology InnovationMarket need/sizeDevelopment stageIPManagementCompetition

LSN’sExpert System

Page 4: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

RESI: Dedicated Investor-Centric Conference

3

In 2013 a typical investor partnering conference you would see a few dozen “actual” investors with credible vetted investment mandates. The rest of the players were 60 or 70 I-Banks, broker dealers or one-man band business development folks who were really service providers claiming to be able to source capital for a monthly stipend (typically 10k PM) but not really investors.

RESI conference changed all that by bringing 400-500 qualified investors with vetted investment mandates to fill the large void that existed:

• There are 2,500 active global investors in LSN’s Salesforce* Investor database• 23% (570 investors) regularly attend 3 or more of the 5 RESI conferences we put on per year.

• There are 4,677 active fundraising CEOs in the LSN’s Salesforce* Company database• 23% (1,084 fundraising CEOS) regularly attend 2 or more RESI Conferences.

• There are 1,300 service providers in the database.• 20% (260) regularly attend 3 or more.

* Accounts that are actively maintained in salesforce.com for RESI recruitment(A subset of the LSN Commercial databases)

Page 5: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

RESI Conference Series Overview

4

GLOBAL VENUES

JAN. @JPM APRIL on MaRS

NOVEMBERJUNE (BIO)SEPTEMBER

FUTURE RESIs

ATTENDEE NUMBERS CONTENT HIGHLIGHTS

300 – 450+FundraisingExecutives

700 – 1,000+Attendees Per

Conference

300 – 450+ Investors and Strategic Partners

100 – 200+ Service Providers

GlobalPartneringForum

InvestorPanels &EntrepreneurWorkshops

Exhibit Hall:Exhibitors& RESIInnovationChallenge

Page 6: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

Attendee Breakdown

5

EARLY STAGE FUNDRAISINGCOMPANIES ACROSS 4 SECTORS

GLOBAL INVESTORSACROSS 10 CATEGORIES

Investor CategoryLarge Pharma/Medtech 23%Venture Capital 20%Family Office/Private Wealth 14%Corporate Venture Capital 13%Angel 10%Government Organization 7%Private Equity 5%Endowment/Foundation 3%Institutional Alternative Investor 3%Hedge Fund 2%

Company SectorTherapeutics 51%Medical Device 25%Diagnostics 13%Healthcare IT 11%

51%

25%

13%

11%

68%

8%

15%

9%

USA

EUROPE

CANADA

ASIA

Therapeutic Product Development Phase

Preclinical56%

Phase I20%

Phase II & Beyond24%

Location

61%

8%

13%

18%

USA

EUROPE

CANADA

ASIA

Location

Page 7: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

POWERING ONE-ON-ONE MEETINGS BETWEEN EARLY-STAGE COMPANIES AND INVESTORS

• Highlights:– 1,200 Meeting slots

– 16 Meeting Opportunities for each attendee

– A 1:1 Company to Investor Ratio

• Online Partnering System Built from LSN’s Proprietary Data Platforms– Comprehensive Profiles of Buyers and Sellers

– Search Capabilities to Target the Best Fit

• Who Meets with Whom at RESI Conferences

Global Partnering Forum

Investor & Startup 71%Startup & Service Provider 13%Investor & Investor 9%Investor & Service Provider 5%Startup & Startup 2%

71%13%

9%5%

2%

6

Page 8: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

• Track 1: Biotech Investor Panels• Track 2: Device, Diagnostic & HCIT Investor Panels• Track 3: Entrepreneur Workshops• Track 4: Asia North America Workshops & Panels

Investor Panels & Entrepreneur Workshops

EXAMPLE:RESI Morning Agenda with Sponsorship Recognition

Photo: RESI Gold Sponsor – McDermott Will & EmeryRunning a Workshop at RESI @ JPM, 2018

EXAMPLE:RESI Panel Lineups

7

Page 9: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

RESI Exhibit Hall

8

• Early-stage companies attending RESI are invited to apply for an Innovation Challenge slot

• 30 of the most innovative companies are selected by LSN’s Expert System and scientific reviewteam to present their technologies in a poster board presentation format

• Attendees will receive “RESI Cash” to allocate to the 30 RESI innovators. Top three winners will receive prizes and be featured in LSN’s newsletter

• Brand yourself as a leader in the life sciences

• Increase exposure to hundreds of early stage companies

• Gain access to funded CEOs through investors’ portfolios

• Unique promotion before, during and after the event offered exclusively to exhibitors

RESI INNOVATION CHALLENGE RESI EXHIBITORS

CRO, CMO, Accounting, Consulting,Regional Life Science Organizations…

Page 10: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

RESI Conference Marketing

• LSN Readership of 30,000 +• Media Partnership Channels• Program Guide & Onsite Signage• Panel Videos• RESI Website• Social Media• Email Marketing

9

RESI Boston 2018 Summer Program Guide

TwitterPanel VideoNewsletter

Page 11: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

Partner Highlights

SPONSORS MEDIA PARTNERS

• Access to partner’s channels and networks• Access to established and emerging technology hubs and their constituents • RESI is recognized as a key player and event in early stage healthcare space

10

Page 12: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

RESI Exhibitor Highlights

260+ HAVE ATTENDED 3 OR MORE EVENTS

11

TESTIMONIALS“RESI holds events in key life science clusters and each one is well attended

by early-stage companies and investors. There is always a high level of energy and attendees are genuinely looking to meet people that can help

them grow their business and this includes services as well as capital.”

Ray BriscusoManaging Producer, AdvaMed

“We see the incredible value out of RESI. RESI is a unique platform connecting the life

science community, particularly early stage companies with the investment community clearly

beyond the VC model.”

Byron KalogerouPartner,

McDermott Will & Emery LLP

“RESI brings together companies that we are not

familiar with. It’s a good place to meet them, understand their

needs and see if we can support them going forward.”

Declan RyanExecutive Director,

WuXi AppTec

Page 13: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

• Asian Panel Track• Mental & Behavior Health• Microbiome Investment• Oncology Innovation• Big Data in Healthcare• Personalized Medicine• Payer & Provider Venture Funds

And more…

• KOTRA

• Taiwan Government

• Astellas Pharma

• WuXi Apptec

RESI Growth and Expansion

Attendee Number Growth Innovative Panels Creation

New Key Asian Partnerships First Coast Innovator’s Gathering

2226Current1596

2394

3306

3960

2015 2016 2017 2018

(Projected)

(Current)2226

12

This fall, RESI will expand to include tech hubs and companies from the First Coast: DC, MD, PA, NJ, NY, RI, CT, and MA.

Grants Seed Angel Series A Series B

Companies Seeking

Page 14: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform 13

Sponsor Levels & Benefits

Page 15: RESI CONFERENCE SERIES - Next Phase Newsletter · • There are 2,500 active global investors in LSN’s Salesforce* Investor database • 23% (570 investors) regularly attend 3 or

© LSN Holdings Global Life Science Partnering Platform

RESI CONFERENCE SERIES

Life Science Nation, LLC9 Hamilton Place, Suite 2B, Boston, MA 02108

Cell: (617) 930 4299Email: [email protected]

www.resiconference.com

Dennis Ford, Founder & CEO, Life Science Nation